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Homa Tajsharghi3,*
ABSTRACT
Myosin is vital for body movement and heart contractility. Mutations in
MYH7, encoding slow/β-cardiac myosin heavy chain, are an
important cause of hypertrophic and dilated cardiomyopathy, as
well as skeletal muscle disease. A dominant missense mutation
(R1845W) in MYH7 has been reported in several unrelated cases of
myosin storage myopathy. We have developed a Drosophila model
for a myosin storage myopathy in order to investigate the dose-
dependent mechanisms underlying the pathological roles of the
R1845Wmutation. This study shows that a higher expression level of
the mutated allele is concomitant with severe impairment of muscle
function and progressively disrupted muscle morphology. The
impaired muscle morphology associated with the mutant allele was
suppressed by expression of Thin (herein referred to as Abba), an E3
ubiquitin ligase. This Drosophila model recapitulates pathological
features seen in myopathy patients with the R1845W mutation and
severe ultrastructural abnormalities, including extensive loss of thick
filaments with selective A-band loss, and preservation of I-band and
Z-disks were observed in indirect flight muscles of flies with exclusive
expression of mutant myosin. Furthermore, the impaired muscle
morphology associated with the mutant allele was suppressed by
expression of Abba. These findings suggest that modification of the
ubiquitin proteasome system may be beneficial in myosin storage
myopathy by reducing the impact of MYH7 mutation in patients.
KEY WORDS: Slow/β-cardiac myosin heavy chain, MYH7, Myosin
storage myopathy, Drosophilamodel, Ubiquitin proteasome system,
E3 ubiquitin ligase, Potential therapeutic approach
INTRODUCTION
Myosin heavy chain (MyHC) is the molecular motor of muscle and
forms the backbone of the sarcomeric thick filaments. It converts
chemical energy of ATP hydrolysis into mechanical force, which is
vital for body movement and heart contractility. Hereditary myosin
myopathies have emerged as an important group of muscle diseases
with variable clinical and morphological expression, depending on
the mutated isoform and location of the mutation (Tajsharghi and
Oldfors, 2013). Mutations in slow/β-cardiac MyHC (MYH7),
expressed in type 1 skeletal muscle fibres and in the heart
ventricles (Smerdu et al., 1994), are associated with skeletal and/
or cardiac myopathies. Mutations mainly located within the globular
head of slow/β-cardiac MyHC are an important cause of
hypertrophic and dilated cardiomyopathy (Walsh et al., 2010),
whereas mutations located at the α-helical coiled-coil C-terminal
rod domain (LMM) cause two skeletal myosin myopathies, Laing
distal myopathy and myosin storage myopathy (MSM), with or
without cardiac involvement (Tajsharghi and Oldfors, 2013).
Mutations in the LMM region can affect the ability of the protein
to form stable and functional thick filaments, based on the amino
acid change, the position in the heptad repeat motif (a-b-c-d-e-f-g)
(McLachlan and Karn, 1982) and the location in the LMM.MSM is
a protein aggregate myopathy associated with myosin accumulation
(Tajsharghi et al., 2003). It is caused by primarily dominant
mutations located within or close to the 29-residue assembly
competence domain in the distal end of the LMM of slow/β-cardiac
MyHC (Tajsharghi and Oldfors, 2013), which is known to be
critical for the proper assembly of sarcomeric myosin rod filaments
(Sohn et al., 1997). Consequently, mutations in this region may
cause defective integration of dimers into the thick filament, leading
to an accumulation of unassembled MyHC. In contrast, mutations
associated with Laing distal myopathy that are situated far from the
assembly competence domain might cause other effects on the thick
filament structure and function leading to a different pathology
(Tajsharghi and Oldfors, 2013). MSM and Laing distal myopathy
show distinct morphological and clinical phenotypes, depending on
the mutated residue at the tail region (Tajsharghi and Oldfors, 2013).
A dominant missense mutation that changes the highly conserved
arginine at position 1845 to tryptophan (R1845W) was the first
MYH7 mutation identified in MSM (Tajsharghi et al., 2003). The
mutated residue is located in the outer f position, in which the side
chains are available to interact with other myosin dimers or other
proteins. This mutation has been reported in several unrelated cases,
confirming the association of the R1845W mutation ofMYH7 with
MSM (Tajsharghi et al., 2003; Laing et al., 2005; Kiphuth et al.,
2010; Pegoraro et al., 2007; Shingde et al., 2006). Muscle biopsy in
affected individuals demonstrates characteristic subsarcolemmal
accumulation of material restricted to type 1 muscle fibres. The
stored material displays myofibrillar ATPase activity and intense
immunoreactivity to slow/β cardiac MyHC, thus the term myosin
storage myopathy was introduced (Tajsharghi et al., 2003).
The clinical manifestations in MSM patients are intra- and extra-
familial highly variable, ranging from mild muscle weakness to
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severe impairment of ambulation (Tajsharghi et al., 2003; Laing et al.,
2005; Pegoraro et al., 2007; Shingde et al., 2006; Stalpers et al., 2011;
Cancilla et al., 1971; Ceuterick et al., 1993; Barohn et al., 1994;
Bohlega et al., 2003; Masuzugawa et al., 1997; Uro-Coste et al.,
2009; Sahgal and Sahgal, 1977). Delayed motor milestones,
difficulties in climbing stairs or running, a waddling gait and
usually proximal muscle weakness in four limbs have been described
in many cases with MSM. The onset of the disease is usually in
childhood and the course is mostly slowly progressive and scoliosis
sometimes supervenes (Stalpers et al., 2011; Bohlega et al., 2003).
The suitability of Drosophila melanogaster as a model organism
for myosin myopathies has been demonstrated in previous studies
(Viswanathan et al., 2017; Dahl-Halvarsson et al., 2018; Wang
et al., 2012; Suggs et al., 2017). This suitability is based on the
largely conserved sarcomeric structure of myofibrils between flies
and human (Reedy and Beall, 1993), as well as the existence of a
single Mhc gene producing all Mhc isoforms through alternative
RNA splicing (Bernstein et al., 1983). Very recently, we used
CRISPR/Cas9 genome engineering to develop the first fly model
for Laing distal myopathy to investigate the pathobiological
mechanisms of the recurrent K1729del MYH7 mutation (Dahl-
Halvarsson et al., 2018). We showed that the corresponding
Drosophila MhcK1728del mutant phenotype recapitulated certain
muscle morphological phenotypes manifest in Laing distal
myopathy patients carrying the K1729del MYH7 mutation.
Furthermore, we identified a potential therapeutic approach
involving the ubiquitin proteasome system (UPS), which
completely rescued the mutant phenotypes.
In this study, we have combined CRISPR/Cas9 genome
engineering and the UAS-GAL4-based gene expression system to
develop fly models for MSM associated with the recurrent R1845W
MYH7 mutation. The UAS-GAL4-based gene expression system
was used to investigate the dose-dependent effect and
pathobiological mechanisms of the MYH7 mutation, and to assess
underlying mechanisms of the aberrant accumulations of myosin in
the muscle fibres of affected individuals with MSM. Moreover,
we identified that increased expression of theDrosophila protein
Thin (herein referred to as Abba), which has essential roles in
maintaining sarcomeric integrity (Domsch et al., 2013; LaBeau-
DiMenna et al., 2012), alleviates the muscle pathological
phenotype.
RESULTS
Viability and lifespan of adult flies
The elongated α-helical coiled-coil C-terminal rod domain of
MyHC exhibits filament-forming properties that assemble into thick
filaments of the sarcomeres. Mutations at the outer f position of the
heptad repeats have been predicted to cause improper filament
formation through disturbed interaction with other myosin dimers
and, thereby, perturb thick filament assembly (Tajsharghi and
Oldfors, 2013). We generated fly models for the recurrent R1845W
mutation, located at the f position of the heptad repeat of α-helical
coiled-coil LMM of MYH7, to investigate the underlying
mechanisms of the pathological features observed in the muscle
fibres of affected individuals with MSM.
Despite extensive efforts, we were unable to establish a fly
carrying the mutant MhcR1844W allele by CRISPR/Cas9-mediated
genome editing, suggesting that the severe impact of this mutation is
incompatible with viability. Thus, we used the UAS-GAL4-based
gene expression system to investigate the dose-dependent effect and
pathobiological mechanisms of the MYH7 mutation. Among the
different Mhc isoforms, we chose the embryonic isoform as it has
been shown to support viability (Wells et al., 1996); although in a
homozygous condition, embryonic Mhc (eMhc) could not support
flight and full jump ability. Yet, the fibres assembled normally and
myofibril ultrastructurewas not dramatically affected.We found that
overexpression of both eMhc and eMhcR1844W using theMef2-GAL4
driver was viable when reared at 25°C, and there was no difference
in lifespan between the two (Fig. 1A). However, unlike
Mef2>eMhc, Mef2>eMhcR1844W flies displayed defects in wing
posture similar to those reported for Mhc10 mutants that selectively
lack Mhc protein in fast-twitch indirect flight muscles (IFMs) and
jumpmuscles (O’Donnell et al., 1989; Nongthomba et al., 2003). At
29°C, when Gal4-mediated overexpression is enhanced,
Mef2>eMhcR1844W animals displayed a significantly shorter mean
lifespan when compared with control animals (Mef2>eMhc)
(P<0.05) (Fig. 1A), and a majority had wing posture defects.
Flies with exclusive expression of eMhcR1844W, but not eMhc, in
indirect flight and jump muscles (Mef2>eMhcR1844W/Mhc10)
showed reduced viability, precluding investigation of muscle
function and fitness. A majority of these flies showed wing
posture defects. Thus, the eMhcR1844W allele has an impact on animal
fitness.
Reduced motility in animals overexpressing
Mef2>eMhcR1844W
Larval turning and crawling assays were used to evaluate muscle
function in Mef2>eMhcR1844W larvae at 25°C and 29°C. In larval
turning assays at 29°C, mutantMef2>eMhcR1844W animals showed a
twofold increase in the time needed to turn over and resume
crawling on the ventral side compared with control animals with
overexpression of wild-type eMhc (Mef2>eMhc) (P<0.001 versus
controls) (Fig. 1B). Mutant Mef2>eMhcR1844W animals showed no
significant changes in larval turning assays at 25°C compared with
control animals (Fig. 1B). Furthermore, Mef2>eMhcR1844W larvae
exhibited a significant reduction in crawling ability compared to the
control animals at 29°C (Mef2>eMhcR1844W: 2.0 cm versus
Mef2>eMhc: 3.2 cm, P<0.001) (Fig. 1C). There was also a
significant reduction in crawling ability between Mef2>eMhcR1844W
andMef2>eMhc animals at 25°C (Mef2>eMhcR1844W: 2.4 cm versus
Mef2>eMhc: 3.1 cm, P<0.05) (Fig. 1C).
Jump, climbing and flight ability was subsequently analysed in
4-day-old, and 2- and 5-week-old flies with overexpression of either
wild-type eMhc or mutant eMhcR1844W allele at 25°C and 29°C.
Jump ability of Mef2>eMhcR1844W flies was impaired at both
temperatures. At 29°C, the jump ability of Mef2>eMhcR1844W flies
decreased by 30% compared with control flies Mef2>eMhc
(P<0.001) at all time points measured (Fig. 1D). There was also a
significant difference in jump ability between 4-day-old
Mef2>eMhcR1844W and 2- and 5-week-old mutant flies (P<0.05).
At 25°C, reduced jump ability of Mef2>eMhcR1844W flies ranged
from 20% to 30% between 4-day-old flies and 2- and 5-week-old
flies (4-day-old Mef2>eMhcR1844W: 2.99 cm versus Mef2>eMhc:
3.65 cm, P<0.05; 2- and 5-week-old Mef2>eMhcR1844W: 2.67 cm
and 2.22 cm versus Mef2>eMhc: 3.61 cm and 2.66 cm, P<0.001)
(Fig. 1D). There was no significant reduction in the jump ability of
4-day-old flies with overexpression of eMhcR1844W at 25°C
compared with Mef2>eMhcR1844W flies at 29°C. However, the
jump ability of 2- and 5-week-old flies with overexpression of
eMhcR1844W at 29°C was significantly reduced compared with
Mef2>eMhcR1844W flies at 25°C (P<0.05) (Fig. 1D).
Rapid iterative negative geotaxis (RING) assessment of
Mef2>eMhcR1844W indicated severely impaired climbing ability in
2-week-old flies compared to controls (P<0.05; Fig. 1E). Unlike
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jump ability, there was a significant decrease in climbing ability
between 4-day- and 2-week-old flies in bothMef2>eMhcR1844W and
control flies (P<0.05; Fig. 1E). Mef2-Gal4-driven expression of
eMhcR1844W, but not of eMhc, also caused loss of flight ability.
Although control flies (Mef2>eMhc) were able to leave the open
vial within 20 min,Mef2>eMhcR1844W flies remained in the vial and
failed to beat their wings, indicating a complete lack of flight ability.
Muscle morphology is disrupted upon expression of
MhcR1844W and worsens over time
The effect of the MhcR1844W allele can be addressed in flight and
jump muscles by overexpressing mutated or wild-type eMhc in flies
carrying the amorphic Mhc10 allele (Mhc1,UAS-eMhcR1844W/
Mhc10;Mef2-Gal4/+ and Mhc1,UAS-eMhc/Mhc10;Mef2-Gal4/+), at
25°C and 29°C. The Mhc1/Mhc10 flies lack functional Mhc in
indirect flight and jump muscles. Immunofluorescence analysis of
myosin (Mhc), Sallimus (also known as Kettin or Titin), which
localises to the Z-disks, and Obscurin (also known as Unc-89)
(Katzemich et al., 2012), which links myosin filaments at the
M-band of the sarcomere in IFM of four-day-old adult flies, could
not detect any clear structural difference between wild-type flies and
flies expressing eMhc in IFM. Additionally, no differences in
muscle structure were detected between animals reared at 25°C and
29°C (Fig. 2A,B), suggesting that an excess amount of eMhc in
itself might not disturb sarcomere structure. In contrast, and in
agreement with a previous study (Viswanathan et al., 2017), we
found that IFMs and jump muscles exclusively expressing
eMhcR1844W (Mef2>eMhcR1844W/Mhc10) display severe sarcomeric
irregularities in 4-day-old adults at both temperatures. Small areas
showed increased myosin immunofluorescence. These undefined
subcellular structures were accompanied by more extensive areas of
sarcomeric disruption, as evident from mislocalization of Mhc,
Sallimus (Kettin) and Obscurin (Fig. 2A,B).
To address the effects of eMhcR1844W expression in animals that
also carry a wild-type copy of Mhc, we further analysed sarcomere
organization in larval body wall muscles from third instar
larvae from animals heterozygous for the Mhc1 allele (w−;Mhc1,
UAS-eMhcR1844W/+;Mef2-Gal4/+ or w−;Mhc1,UAS-eMhc/+;Mef2-
Fig. 1. Impaired muscle function in eMhcR1844Woverexpressing flies. The phenotypic effect of the eMhcR1844Wallele was studied by overexpression of either
mutated or wild-type eMhc in flies with a heterozygote null Mhc allele (Mhc1) background. (A) Mef2>eMhcR1844W/+ adult flies exhibited significantly shorter
lifespans compared to control flies (Mef2>eMhc) at 29°C (Mef2>eMhcR1844W versusMef2>eMhc). At 25°C, themutants had a tendency to have a shorter lifespan
but this difference was not significant. (B) At 29°C, the Mef2>eMhcR1844W larvae showed a significant increase in the time needed to turn belly-down when
placed on their backs, whereas no significant increase in time was seen for the Mef2>eMhcR1844W larvae at 25°C, when compared to controls (Mef2>eMhc).
(C) Mef2>eMhcR1844W larvae showed a significant reduction in crawling ability at 25°C, whereas the crawling speed of mutant larvae was reduced to a highly
significant degree at the third instar larval stage at 29°C. (D) Jump ability ofMef2>eMhcR1844W flies are reduced at 25°C and 29°C, compared to controls. At 29°C,
Mef2>eMhcR1844W display a highly significant reduction at all time points. At 25°C, the reduction of jump ability for 4-day-old flies was significant and highly
significant for 2-week- and 5-week-old flies. There was no significant difference between 4-day-oldMef2>eMhcR1844W flies when kept at 25°C and 29°C, but the
jump ability of Mef2>eMhcR1844W flies significantly declined at 2 weeks of age at 29°C, compared to the mutant flies at 25°C. (E) Climbing ability of
Mef2>eMhcR1844W flies at 29°C was severely impaired compared to control flies (P<0.001) at all time points measured. There was no significant difference in
climbing ability between 4-day-old flies of both genotypes at 25°C, but the deterioration was significant at 2 weeks and 5 weeks of age betweenMef2>eMhcR1844W
and control flies. Data are mean±s.e.m. Statistical significance was determined using the Kaplan–Meier estimator. *P<0.05; **P<0.001; ns, not significant.
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Gal4/+) and reared at either 25°C or 29°C. Mhc1/+;
Mef2>eMhcR1844W larvae displayed a severely disrupted sarcomeric
structure, including thickened and less defined Mhc-containing
A-bands and slightly wider and jagged Z-disks and M-bands in the
bodywall muscle compared withMhc1/+;Mef2>eMhc larvae at 25°C
(Fig. 3A). The sarcomeric disruption was more severe in animals
raised at 29°C, and an increased myosin immunofluorescence was
evident in some areas (Fig. 3B). Z-disks andM-bands appearedwider
and jagged, andMhc failed to concentrate in distinct A-bands at either
side of the Z-disk and instead occupied nearly the entire space
between the Z-disks in Mef2>eMhcR1844W larvae at 29°C.
Immunofluorescence analysis of Unc-45 (which is essential for the
folding of Mhc and localises to the Z-disks) Mef2>eMhcR1844W
larvae displayed undefined Unc-45-containing Z-disks at both
temperatures (Fig. 3A,B).
Different Mhc isoforms are normally expressed in larval and IFM
of adult flies due to developmentally and spatially regulated
alternative RNA splicing of a single Drosophila muscle mhc gene,
(Bernstein et al., 1983). Therefore, to explore potential progressive
effects of the eMhcR1844W allele on sarcomere structure, we analysed
the IFMs of 4-day-old, and 2- and 5-week-old adult flies at 25 and
29°C. Immunofluorescence analyses of Mhc, Sallimus (Kettin/
Titin) and Obscurin revealed a disrupted sarcomere structure with
few intact sarcomeres in adult flies overexpressing eMhcR1844W
compared to flies overexpressing eMhc. As we observed previously,
at 25°C, IFMs of 4-day-old adult flies generally displayed less
Fig. 2. Muscle morphology in IFMs of 4-day-old eMhcR1844W/Mhc10 adult flies. (A,B) IFMs were labelled for Myosin (Mhc), Kettin/Titin and Obscurin in
4-day-old Mef2>eMhc or Mef2>eMhcR1844W flies carrying the amorphic Mhc10 allele at 25°C (A) and 29°C (B). Each panel shows Mef2>eMhc control animals
(w−;Mhc1,UAS-eMhc/Mhc10;Mef2-Gal4/+) (top) and Mef2>eMhcR1844W animals (w−;Mhc1,UAS-eMhcR1844W/Mhc10;Mef2-Gal4/+) (bottom). In A and B, control
flies showed parallel periodic striations across the IFMs. In A, IFMs of the Mef2>eMhcR1844W/Mhc10 flies, with exclusive expression of the eMhcR1844W allele,
displayed severe sarcomeric irregularities with few intact sarcomere structures. In B, IFMs of Mef2>eMhcR1844W/Mhc10 displayed an absence of periodic
sarcomere structure, with some areas showing increased myosin immunofluorescence, probably indicating myosin accumulation. Z and M indicate Z-disks and
M-bands, respectively. Scale bar: 10 μm.
Fig. 3. Muscle morphology in eMhcR1844W mutants. (A,B) Larval body wall muscles were labelled for Myosin (Mhc), Kettin/Titin and Obscurin or Mhc,
Kettin/Titin and Unc45 at 25°C (A) and 29°C (B). Each panel showsMef2>eMhc control animals (w−;Mhc1,UAS-eMhc/+;Mef2-Gal4/+) (top) andMef2>MhcR1844W
animals (w−;Mhc1,UAS-eMhcR1844W/+;Mef2-Gal4/+) (bottom). In A, at 25°C, Mef2>eMhcR1844W larvae displayed disrupted sarcomeric structure, including
less defined and thickened A-bands, jagged Z-disks and M-bands. Unc45-containg Z-disks were incompletely defined. In B, at 29°C, at Mef2>eMhcR1844W
animals showed severely disrupted sarcomeric structure and areas with accumulations of Mhc without distinct A-band and wider and jagged Z-disks and
M-bands. Unc45 was dispersed throughout the muscle with no clear pattern. Z, A and M indicate Z-disks, A-bands and M-bands, respectively. Scale bar: 10 µm.
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structured and separated Mhc-containing A-bands and M-bands,
whereas Sallimus (Kettin/Titin) was detected in the distinct but
slightly disorganised Z-disks (Fig. 4A, upper panel). Sarcomeric
irregularities were more evident in 2- and 5-week-old animals,
which exhibited some areas with undefined A-bands, M-bands and
Z-disks in the IFM at 25°C. Furthermore, regions of myofibril
atrophy could be seen in 5-week-old flies (Fig. 4A,B, lower panel).
At 29°C, IFMs of 4-day-old, and 2- and 5-week-old adult flies,
displayed severe sarcomeric disruption (Fig. 4B). Structured
sarcomeric organisation was barely evident in 5-week-old flies at
29°C (Fig. 4B, lower panel). Thus, expression of eMhcR1844W
appears to result in a progressive worsening of adult muscle
phenotype in an expression level- and age-dependent manner that is
not seen with eMhc.
Ultrastructural impairment on expression of eMhcR1844W
Ultrastructural analysis of the IFM was performed on 7-day-old
adult flies at 25°C. Well-organised sarcomeres with preserved Z-disk
and M-bands were observed in IFMs of control flies (Mef2>eMhc)
(Fig. 5A-C). Only small morphological abnormalities were identified
in IFMs of flies with overexpression of eMhc (Fig. 5B,C). In contrast,
in the IFMs of Mef2>eMhcR1844W flies, fibres displayed severe
sarcomeric disorganization. Neither I-bands (the zone in which the
thin filaments do not overlap the thick filaments) nor M-bands were
visible and the Z-disks were disrupted (Fig. 5D,E, higher
magnification). Thick filament accumulation (Fig. 5F, red arrow),
small aggregates of electron-dense material of Z-disk origin (Fig. 5F,
black arrows) and abnormal mitochondria (Fig. 5G-I) (asterisk in G
and white arrows in H and I) were observed in the IFMs of
Mef2>eMhcR1844W flies. More severe ultrastructural abnormalities,
including extensive loss of thick filaments with selective A-band loss
and preservation of I-band and Z-disks, were observed in the IFMs of
Mef2>eMhcR1844W/Mhc10 flies (Fig. 5J,K, black arrows). In addition,
there were small collections of disorganised thick filaments (Fig. 5L,
red arrow) and abnormal mitochondria (Fig. 5L, asterisk). In the
IFMs ofMef2>eMhc/Mhc10 flies, sarcomeres were disorganised and
had severe Z-disk fragmentations (Fig. 5M-O). However, in contrast
to the IFMs of Mef2>eMhcR1844W/Mhc10 flies, which exhibited an
almost complete absence of thick filaments,Mef2>eMhc/Mhc10 flies
had easily recognizable thick filaments. Only small occasional
regions were devoid of myosin filaments (Fig. 5N,O, arrows).
Overexpression of Abba suppresses eMhcR1844W- induced
muscle defects
We have previously shown that Abba expression alleviates muscle
defects associated with the MhcK1728del mutation in a Drosophila
model of Laing distal myopathy (Dahl-Halvarsson et al., 2018).
Muscle defects induced byMhcK1728delwere completely suppressed
by overexpression of Abba (Dahl-Halvarsson et al., 2018). In
Drosophila, Abba (another B-box affiliate) belongs to the TRIM/
RBCC protein family and is required for sarcomeric integrity during
muscle formation and function, and Abba mutants display an
abnormal accumulation of Mhc structures (Domsch et al., 2013;
LaBeau-DiMenna et al., 2012). In humans, muscle-specific RING
Fig. 4. Muscle morphology in IFMs of eMhcR1844Wexpressing adult flies. (A,B) IFMs were labelled for Mhc, Kettin/Titin and Obscurin in 4-day-old, and 2- and
5-week-old adult flies kept at 25°C (A) and 29°C (B). Each panel shows Mef2>eMhc control animals (w−;Mhc1,UAS-eMhc/+;Mef2-Gal4/+) (top) and
Mef2>eMhcR1844W animals (w−;Mhc1,UAS-eMhcR1844W/+;Mef2-Gal4/+) (bottom) for each age group. In both A and B, control flies showed parallel periodic
striations across the IFMs. (A)Mef2>eMhcR1844Wanimals showed progressive disruptions in sarcomeric structure with age. Four-day-oldMef2>eMhcR1844W flies
displayed less structured and defined A-bands and M-bands. Two- and 5-week-old adult myofibrils of Mef2>eMhcR1844W flies showed myofibril atrophy with
undefined A-bands, M-bands and Z-disks. (B) At 29°C, IFMs of 4-day-old, and 2-week-old adultMef2>eMhcR1844W flies, displayed severe sarcomeric disruption
with few intact sarcomere structures. Five-week-old adultMef2>eMhcR1844W flies were frequently missing defined sarcomere structures. Z andM indicate Z-disks
and M-bands, respectively. Scale bar: 10 µm.
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finger (MuRFs) proteins are members of the TRIM/RBCC
superfamily of E3-ligases and regulate degradation of MyHCs.
MuRF1 (also known as TRIM63) deficiency combined with a
deleterious MuRF3 (also known as TRIM54) mutation leads to
subsarcolemmal accumulation of myosin (Olive et al., 2015),
similar to the muscle morphological features of MSM (Tajsharghi
and Oldfors, 2013). We therefore investigated whether elevated
levels of Abba expression have any effect onmuscle defects induced
by expression of eMhcR1844W. In flies overexpressing eMhcR1844W,
overexpression of Abba did not result in a significant rescue of flight
ability. However, overexpression of Abbawas able to improve some
muscle functions inMef2>eMhcR1844W animals. The jump ability of
Fig. 5. Transmission electron micrographs of IFMs in eMhcR1844W expressing flies. Transmission electron micrographs of IFMs in 7-day-old control (A-C),
Mef2>eMhcR1844W (w−;Mhc1,UAS-eMhcR1844W/+;Mef2-Gal4/+) (D-I), Mef2>eMhcR1844W/Mhc10 flies (w−;Mhc1,UAS-eMhcR1844W/Mhc10;Mef2-Gal4/+) (J-L), and
Mef2>eMhc/Mhc10 flies (w−;Mhc1,UAS-eMhc/Mhc10;Mef2-Gal4/+) (M-O), at 25°C. (A-C) Control flies showed well-preserved sarcomere structure with well-
defined Z-disks, A-bands and M-bands. (D-F) Transverse sections of Mef2>eMhcR1844W flies revealed fibres with prominent abnormalities in the sarcomeric
structure with lack of I-bands and M-bands and disrupted Z-disks. (E) A higher magnification of sarcomeric disorganization with absence of I-bands and M-bands
and disrupted Z-disks in longitudinal sections. (F) Areas with thick filament accumulation (red arrow) and small aggregates of Z-disk-derived material (black
arrows). (G-I) Apart from thick filaments accumulation, there were prominent mitochondria abnormalities with abnormal cristae (asterisk in G) and small electron-
dense inclusions (white arrows in G-I). (J,K) IFMs of Mef2>eMhcR1844W/Mhc10 flies revealed a severe loss of thick filament with selective A-band loss (black
arrows) and preserved I-band and Z-disks. (L) Small areas containing disorganised thick filaments (red arrow) and abnormal mitochondria (asterisk). (M-O) IFMs
of Mef2>eMhc/Mhc10 flies revealed severe sarcomere disorganization with fragmented Z-disks. Thick filaments were preserved (black arrows, M-O), except
in small areas that were devoid of thick filaments (white arrows, N and O). The sarcomeric structural parts, Z-disks and M-bands, are labelled. Scale bars: 2 µm
(A,C,D); 1 µm (B,F,M,N); 0.5 µm (E,G-L,O).
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mutant Mef2>eMhcR1844W flies was restored almost to that of the
wild type upon muscle-specific expression of Abba at 25°C and
29°C (Fig. 6A). At 25°C, there was no difference in climbing ability
between Mef2>eMhcR1844W and Mef2>eMhc control animals, and
expression of Abba revealed no changes, but climb ability of mutant
Mef2>eMhcR1844W flies was significantly improved by increased
levels of Abba at 29°C (Fig. 6B). Thus, some muscle dysfunction
caused by eMhcR1844W can be alleviated by increased levels of
Abba, although flies remained flightless. To assess the morphology
of the IFMs in Mef2>eMhcR1844W and Mef2>eMhcR1844W;
Mef2>Abba animals, we again used antibodies against Mhc,
Sallimus (Kettin/Titin) and Obscurin. Immunofluorescence
analyses revealed a slightly sarcomeric disorganisation in
eMhcR1844W flies with limited Abba overexpression at 25°C
(Fig. 6C). In contrast, an apparent improvement of sarcomeric
organization was revealed in these flies with distinct Z-disks,
M-bands and Mhc-containing thick filaments at 29°C (Fig. 6D).
A nearly complete rescue at the morphological level was observed
in the entire muscle in repeated experiments. Moreover, the
distinct areas of increased myosin immunofluorescence that were
observed in 4-day-old Mef2>eMhcR1844W flies were not detected in
Mef2>eMhcR1844W flies that overexpressed Abba at 29°C (Fig. 6D).
These findings indicate that elevated levels of Abba are able to
relieve muscle morphological defects associated with the
eMhcR1844W allele in the presence of wild-type Mhc.
As the simultaneous overexpression of both eMhc and Abba is
under the control of theMef2 promoter and the GAL4 system driver,
the expression level of eMhc in the transgenic lines was determined.
Results obtained from the immunoblot assay indicated similar
expression levels of eMhc in animals with overexpression of
eMhcR1844W or the eMhc allele with or without overexpression of
Abba at 25°C or 29°C (Fig. 7A,B). Furthermore, results from the
immunoblot assay confirmed that the expression level of the UAS-
eMhc in Mhc1 embryos induced by the Mef2-Gal4 driver was
clearly lower than the expression level of endogenous myosin in w−
control flies at 25°C or 29°C (Fig. 7C). These results ruled out the
possibility of extreme expression levels of myosin under the control
of the Mef2 promoter, which might titrate out other sarcomeric
components and consequently lead to impaired muscle
morphology. Furthermore, in flies overexpressing eMhcR1844W,
Abba overexpression alleviates the pathological phenotypes of
muscle structure, suggesting that the disruptions of the sarcomeres
observed in the fly muscle were associated with the mutant allele
rather than a high level of myosin protein.
Collectively, these data show that Abba expression levels
modulate the muscle phenotype observed in Mef2>eMhcR1844W
animals, with elevated Abba levels restoring muscle morphology.
Although increased Abba levels enhanced some muscle function,
flight ability in flies was not rescued, suggesting that embryonic
Mhc is dominant antimorphic.
Fig. 6. Rescue of 4-day-old Mef2>eMhcR1844W fly muscle function and morphology with overexpression of Abba. (A) Jump ability of Mef2>eMhcR1844W
flies was restored upon overexpression of Abba (Mef2>eMhcR1844W; Mef2>Abba) to levels comparable with controls Mef2>eMhc, at both temperatures
at 4 days of age. (B) Climbing ability of Mef2>eMhcR1844W and control animals was comparable at 25°C, and no changes were observed on overexpression of
Abba. The climbing ability ofMef2>eMhcR1844W; Mef2>Abbawas significantly improved upon overexpression ofAbba at 29°C (P<0.05). (C-D) IFMs were labelled
for Mhc, Kettin/Titin and Obscurin in 4-day-old adult flies at 25°C (C) and 29°C (D). (C) Mef2>Mhc control flies, with overexpression of Abba (Mef2>eMhc;
Mef2>Abba), showed parallel periodic sarcomeric striations in the IFMs. Less defined sarcomeric structure was observed in the IFMs of Mef2>MhcR1844W flies.
Mef2>eMhcR1844W flies with overexpression of Abba (Mef2>eMhcR1844W; Mef2>Abba) at 25°C displayed almost structured periodic striations with
slightly sarcomeric disorganisation. (D) Few intact sarcomeres were observed in the IFMs of Mef2>MhcR1844W flies at 29°C. Overexpression of Abba in
Mef2>eMhcR1844W flies (Mef2>eMhcR1844W; Mef2>Abba) at 29°C resulted in structured periodic sarcomeric striations, comparable with Mef2>eMhc
control flies. The sarcomeric structural parts, Z-disks and M-bands, are labelled. Scale bar: 10 µm.
7



















Several in vitro and in vivo studies have been performed to
investigate molecular mechanisms involved in the pathogenesis of
diseases caused by mutations in the rod region of muscle MyHC.
Biochemical and biophysical characterization of the effects of the
myosin storage myopathy mutations in the LMM region have
suggested adverse effects of the mutations in the ability of the
protein to form stable and functional thick filaments (Armel and
Leinwand, 2009), and that each mutation has a unique effect on the
ability to form accumulated materials (Dahl-Halvarsson et al.,
2017). However, it is still unclear why Laing distal myopathy and
MSM are associated with different muscle pathologies.
MSMmodels of 1-day-old flies were previously generated to study
the impact of threeMSMmutations, including the R1845Wmutation,
on muscle performance (Viswanathan et al., 2017). Flies with
exclusive expression of mutant MhcR1844W allele in IFM exhibited
severe impairment of flight and jump ability concomitant with
progressive disrupted muscle ultrastructure and myosin aggregates
(Viswanathan et al., 2017). In this study, we have established an
MSM model of the recurrent R1845W mutation in Drosophila to
provide insight into the mechanisms governing the muscle
involvement and the development of the disease in an extended
age- and dose-dependent manner. Furthermore, we explored a
potential therapeutic approach involving myosin degradation via the
UPS in MSM. The MhcR1844W allele, corresponding to the recurrent
R1845W mutation in slow/β cardiac MyHC, represents a disease
model for the first and the most common MSM-causing mutation
(Tajsharghi et al., 2003; Tajsharghi et al., 2007; Tajsharghi and
Oldfors, 2013). The disease is slowly progressive, the severity of
myopathy is not related to age, and evidence of cardiomyopathy
associated with the myopathy is usually not found (Tajsharghi et al.,
2003; Tajsharghi and Oldfors, 2013). Muscle biopsy is characterised
by stored material with intense immunoreactivity to slow/β cardiac
MyHC (Tajsharghi and Oldfors, 2013). The inclusion bodies are not
limited by a membrane but the stored material can be seen between
partly disintegrated myofibrils in the vicinity of the main storage
body, and at higher magnification they have a granular appearance
(Tajsharghi and Oldfors, 2013).
Our analyses of eMhcR1844W Drosophila muscle revealed some
large areas with increased myosin immunofluorescence, indicating
myosin accumulation, reminiscent of the stored material observed in
muscle biopsies from patients carrying MSM-associated mutations,
including the R1845W mutation. A near total absence of structured
sarcomeric organisation was evident in 5-week-old mutant flies
with high expression level of MhcR1844W allele. Thus, eMhcR1844W
appears to result in an age- and expression-level-dependent
progressive worsening of adult muscle phenotype. In addition, it
is likely that the mutant myosin is more subject to denaturation at an
elevated temperature correlated with a higher expression level,
leading to enhanced phenotypes. The expression of the mutated
eMhcR1844W allele in an otherwise wild-type situation caused
sarcomere disruption, indicating that expression of the mutant allele
is the underlying cause of the phenotype. This correlated with
ultrastructural findings demonstrating sarcomeric disorganization
and areas with accumulation of thick filaments, which failed to
integrate into sarcomeres resembling the situation observed in the
muscle biopsies of MSM patients (Tajsharghi and Oldfors, 2013).
However, unlike muscle biopsies of MSM patients, the inclusions
did not appear as granular material. In addition, the Z-disks
appeared disrupted. Together, this indicates the actual impact of
Fig. 7. Mhc expression levels in transgenic
lines. (A,B) Relative Mhc expression levels in
4-day-old transgenic lines were determined
using immunoblot analysis. Protein extracted
from transgenic lines carrying UAS-eMhc
(Mef2>eMhc) or UAS-eMhcR1844W
(Mef2>eMhcR1844W), and transgenic flies
used in the assessment of rescuing the
effect of simultaneous overexpression of
eMhc and Abba (Mef2>eMhc; Mef2>Abba)
or UAS-eMhcR1844W (Mef2>eMhcR1844W;
Mef2>Abba), at 25°C and 29°C, were
analysed. w− strain flies were used as
controls. Similar expression levels of eMhc in
animals with overexpression of eMhcR1844W,
or eMhc allele with or without overexpression
of Abba at 25°C (A) or 29°C (B), are indicated.
Myosin and total protein expression are
indicated (arrow). (C) Assessment of the
overexpression ability of Mef2-Gal4 system.
The Mef2-Gal4 driver induced the expression
of UAS-eMhc in the Mhc1 null strain, when
compared to Mhc1 null embryos. Lower
expression levels of eMhc allele in Mhc1
embryos at 25°C or 29°C, compared with
myosin levels in w− wild-type control, are
indicated. Myosin and alpha-tubulin
expressions are indicated (arrows).
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the R1844W mutation on muscle architecture, with decreased
myosin filament stability and myofibrillar disassembly leading to
a progressive myofibril degeneration. This muscle pathology
differs from the abnormalities observed in a Drosophila model of
the Laing distal myopathy (MhcK1728del flies), which shows large
areas of sarcomeric disorganization, with Z-disk streaming and
extensions as the main muscle morphological features (Dahl-
Halvarsson et al., 2018).
Consistent with their aberrant muscle architecture, eMhcR1844W
flies also display defects in flight, jumping and climbing ability, as
well as a reduced lifespan. Impaired larval muscle functions, such
as turning from belly-up to belly-down, were observed in
eMhcR1844W mutants during first and second larval instar, and the
severity of muscle weakness is related to the expression level of
the eMhcR1844W allele. The phenotype is consistent with the
demonstrated severe sarcomere abnormalities, disintegration of
sarcomeric structure and mislocalization of core components, such
as UNC45, Kettin/Titin andM-bands, indicating a marked impact of
the mutated myosin on muscle function.
IFMs of Mef2>eMhcR1844W/Mhc10 animals, with exclusive
expression of the MhcR1844W allele, revealed more severe
ultrastructural abnormalities, with completely disrupted myofibrillar
structures, very few intact sarcomeres and a massive loss of thick
filaments with selective A-band loss and preservation of I-band and
Z-disks. These ultrastructural features are identical to those observed
in muscle biopsies from patients with critical illness myopathy
(Larsson et al., 2000), which results from massive degradation of
MyHC by the UPS. Interestingly, MuRF1 has been found to be
upregulated in skeletal muscle from critical illness myopathy patients,
demonstrating the involvement of MuRF1 in thick filament
degradation (Larsson et al., 2000).
The development of cardiomyopathy and skeletal myopathy
associated with subsarcolemmal myosin accumulation and non-
ubiquinated aggregates of fragmented sarcomeres were observed in a
patient with compound MuRF1 (TRIM63) deficiency and a
deleterious MuRF3 (TRIM54) missense mutation (Olive et al.,
2015). Highly similar features were previously observed in mice
deficient for MuRF1 and MuRF3 (Fielitz et al., 2007). The TRIM/
RBCC family includes theMuRFE3 ubiquitin ligases, which catalyse
the degradation of MyHCs via the UPS in the muscle (Freemont,
2000; Glass and Roubenoff, 2010). In Drosophila, Abba protein,
which is homologous to human TRIM E3 ubiquitin ligase, has a
fundamental role in maintaining myofibril bundling and sarcomeric
integrity during muscle development and usage (Domsch et al., 2013;
LaBeau-DiMenna et al., 2012). Flies with Abba deficiency displayed
similar muscle phenotypes, as seen in double knockout mice and in
patients with compoundMuRF1 deficiency and a deleteriousMuRF3
mutation (Domsch et al., 2013; LaBeau-DiMenna et al., 2012).
A lack of ubiquitin in the inclusions found in the patient with
compound MuRF1 deficiency and a deleterious MuRF3 missense
mutation (Olive et al., 2015), and in MSM patients (Tajsharghi
et al., 2003; Tajsharghi and Oldfors, 2013), as well as in the IFMs of
flies with MSM-associated mutations (Viswanathan et al., 2017),
indicates that mutant myosin in the aggregates are not targeted for
degradation by the UPS. Thus, thick filament protein aggregations
that contribute to the disease phenotype can be caused by MSM-
associated mutations inMYH7 and defective degradation of myosin
by the UPS in muscle. This offers an efficient tool for exploring
potential therapeutic approaches involving UPS to alleviate thick
filament protein aggregation and being beneficial in MSM.
Recently, we showed that overexpression of Abba can restore
muscle function and morphology in a Drosophila model of Laing
distal myopathy with MhcK1728del mutation. Abba overexpression
fully suppressed the phenotypic effects of heterozygousMhcK1728del.
However, reduced Abba levels in animals heterozygous for
AbbaMJO0348 enhanced the muscle defects associated with the
heterozygous MhcK1728del condition, showing that Abba functions
to counteract the deleterious effects ofMhcK1728del (Dahl-Halvarsson
et al., 2018). Here, we further show that overexpression of Abba can
restore muscle morphology in flies with eMhcR1844W mutation.
Although some muscle dysfunction was enhanced, lack of flight
ability was, however, not rescued by overexpression of Abba in flies
with eMhcR1844W mutation. This can be explained by a dominant
antimorphic feature of embryonic Mhc, as previously demonstrated
(Wells et al., 1996). In addition, the results from immunoblot analyses
indicated similar expression levels of eMhc in animals with
overexpression of eMhcR1844W or eMhc allele, with or without
overexpression of Abba. This ruled out the possibility that an
insufficient amount of Abba due to competitive expression levels
between Abba and eMhc or eMhcR1844W, given that the muscle-
specific Mef2-Gal4 driver concurrently induced the expression of
both UAS-Abba and UAS-eMhc or UAS-eMhcR1844W, was unable to
adequately rescue the flight muscle function. Partial rescue of muscle
function in eMhcR1844W flies may also reflect the more severe impact
of the R1844Wmutation compared to the Laing models, in which we
observed complete rescue of muscle phenotypes in the MhcK1728del
flies with overexpression of Abba (Dahl-Halvarsson et al., 2018).
This is in line with the failure to generate an MSM model in
Drosophila by CRISPR/Cas9-mediated genome editing. Given that
wewere able to modify the R1844 sitewithout creating an amino acid
change, it is possible that the mutant MhcR1844W allele resulted in
lethality and thus we were unable to identify and generate a fly line
harbouring the MhcR1844W allele. The milder effect of the MYH7
R1845W mutation in patients and on embryonic viability might be
explained by the existence of embryonic and perinatal MyHC
isoforms, encoded by MYH3 and MYH8, respectively, which are
expressed during fetal development and muscle generation (Feghali
and Leinwand, 1989; Karsch-Mizrachi et al., 1989).
Taken together, data from the current study indicates that the
observed variation in clinical and pathologic phenotypes of slow/β
cardiac MyHC mutation is mutation-specific and that it may in part
be due to the genetic background related to the existence of E3-
ligase modifier genes that may reduce or enhance the impact of the
mutation, as previously suggested in our study of a Laing distal
myopathy model in Drosophila (Dahl-Halvarsson et al., 2018).
In conclusion, we have generated a Drosophila MSM model, and
show that severity of the disease correlates with the expression levels of
the mutated allele. In addition, the muscle morphology phenotypes and
somemuscle dysfunctions associated with theMhcR1844W condition are
suppressed by overexpression of the TRIM family protein Abba.
MATERIALS AND METHODS
Experimental approaches to generate aMhcR1844W mutant allele
CRISPR/Cas9 genome editing
The engineering of the Drosophila genome was performed via CRISPR/
Cas9-mediated genome editing. The targeting sequence (5′-
GCTGAGCTTCCAGTCCGAGGAGG-3′) was cloned into the pCFD3-
dU6:3gRNA plasmid and co-injected with a 177 bp long single-stranded
oligodeoxynucleotide (ssODN) in fly embryos expressing Cas9 during
oogenesis (y1 M{vas-Cas9}ZH2A w1118) (BestGene). The ssODN donor
encompassed thewild-type R1844 or R1844Wmutation (CGT>TGG) and a
silent mutation located at position 5687 (NM_165191) (GGACC>AGACC)
to remove an AvaII enzyme digestion site in the presence of the R1844W
mutation. The genomic region of interest was amplified by PCR fromwhole-fly
extracts anddigestedwithAvaII to identify theR1844Wmutation.The resultwas
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confirmed by sequencing of exons over the entireMhc locus. Thismay indicate a
major impact of the heterozygous MhcR1844W allele on viability. The
heterozygous wild-type Mhc allele was maintained as a stock over a CyO
balancer chromosome carryingDeformed>YFP. HeterozygousMhcR1844W flies
could never be maintained despite repeated injections.
Construction of UAS-Mhc
The pUASTaAttB vector (FlyBase ID: FBmc0003002) was used as the
construct backbone. Available AttB sites flanking the upstream
activation sequence (UAS) promoter and cDNA fragment allow site-
directed insertion into the Drosophila genome upon injection into a
specific strain that carries corresponding AttP-sites at a given genomic
location. Two plasmids covering the embryonic Mhc (eMhc) cDNA, a 5′
part (covering exons 1-12) and a 3′ part (covering exons 12-19) both
carried in the BlueScript-KS vector, were kindly provided by S.I.
Bernstein (San Diego State University, CA, USA). The two eMhc cDNA
fragments were combined by excision of the 5′ part with XbaI and ApaI,
followed by subcloning into the BlueScript-KS vector containing the 3′
fragment cut with the same restriction enzymes. The resulting full-
length eMhc cDNA was excised using NotI and KpnI restriction
enzymes and ligated into the pUASTaAttB vector, which was digested
with the same enzymes. The eMhc R1844W mutation (corresponding to
R1845W in humans) was introduced by QuikChange II (Agilent
Technologies) into the full-length wild-type eMhc cDNA fragment
(GenScript). The wild-type and mutated eMhc constructs were validated
by sequencing of the entire cDNAs.
Drosophila genetics and lines
Fly culture, crosses and analyses were performed on standard fly food and at
room temperature (22°C), unless otherwise stated. The w1118 (w−) line was
used as awild-type genetic background. Transgenic lines carryingUAS-eMhc
or UAS-eMhcR1844W on a attP landing site on the second chromosome were
generated in a w− background (w−;UAS-eMhc and w−;UAS-eMhcR1844W)
(BestGene) and balanced over CyO, Deformed-YFP (Bloomington Stock
Center). Flies carrying the loss-of-function alleleMhc1 or the amorphicMhc10
allele that results in undetectable levels of Mhc in the IFM and jump muscle
(Collier et al., 1990) were kindly provided by S.I. Bernstein (San Diego State
University). Flies carrying UAS-Abba on the third chromosome (w−; UAS-
Abba) were kindly provided by Dr H. Nguyen (University of Erlangen-
Nuremberg, Germany). The muscle-specific Mef2-Gal4 driver (expressing
Gal4 inmuscle lineages), obtained from the Bloomington Stock Center (stock
number 27390), was used to induce UAS-eMhc or UAS-eMhcR1844W
overexpression. As Gal4 activity increases with temperature, the level of
transgene expression can be modulated by altering the rearing temperature.
This was used to correlate expression levels with phenotype.
The phenotypic effect of the MhcR1844W allele was studied by
overexpression of either mutated or wild-type eMhc in flies with a
heterozygote null Mhc allele (Mhc1) background (w−;Mhc1,UAS-
eMhcR1844W/+;Mef2-Gal4/+ or w−;Mhc1,UAS-eMhc/+;Mef2-Gal4/+) at
25°C and 29°C. The exclusive effect of the MhcR1844W allele in flight and
jump muscles was further studied by overexpression of mutated or wild-type
eMhc in flies carrying the amorphic Mhc10 allele (w−;Mhc1,UAS-
eMhcR1844W/Mhc10;Mef2-Gal4/+ and w−;Mhc1,UAS-eMhc/Mhc10;Mef2-
Gal4/+), at 25°C and 29°C. The rescuing effect of overexpression of Abba
in animals expressing eMhcR1844W (w−;Mhc1,UAS-eMhcR1844W/+;UAS-Abba/
Mef2-Gal4 or w−;Mhc1,UAS-eMhc/+;UAS-Abba/Mef2-Gal4) were analysed
at 25°C and 29°C.
Larval motility assays
The crawling assay was performed with third instar larvae, as described
previously (Nichols et al., 2012; Dahl-Halvarsson et al., 2018). Briefly,
single larvae were transferred to 9 cm apple juice plates and the position of
the animal was recorded for 1 min to trace the movements. At least twenty
animals of each genotype were analysed. In the larval turning assay (Estes
et al., 2011; Dahl-Halvarsson et al., 2018), third instar larvae were placed on
apple juice plates and gently rolled ventral side up. The time taken for larvae
to return to a dorsal side up position and continue their forward movement
was recorded.
Jumping and flight assays in adult flies
Four-day-old, 2-week-old and 5-week-old flies were evaluated for jump and
flight abilities. The jump assay was essentially performed as described
previously (Swank et al., 2002) (Dahl-Halvarsson et al., 2018); jump ability
was defined as the horizontal distance a fly was able to jump from a 7-cm-
high platform. Wings were removed before jump testing. Twenty flies per
genotype were assessed in ten replicates. Flight ability was assessed for
20 min at room temperature in a transparent vial (9 cm high, internal
diameter 2.6 cm) with a light source at the top of the vial to encourage flies
to fly. The vial was agitated every 5 min. Flies that were not able to perform
flight motion within 20 min, and fell straight to the bottom when the bottle
was tapped, were considered flightless. The experiment was recorded and
individual flies were carefully analysed. Twenty flies per genotype were
assessed in five replicates.
RING assay
Four-day-old, 2-week-old and 5-week-old flies were evaluated for negative
geotaxis, an innate escape response driven by mechanical stimulation of the
flies. The RING assay was performed as described previously (Dahl-
Halvarsson et al., 2018). Briefly, the position of the flies in the tubes were
captured in digital images taken 3 s after initiating the behaviour/tapping.
The RING was assessed in a total of five consecutive trials separated by
1 min of rest for each genotype and age group at room temperature in a
transparent vial (9 cm high, internal diameter 2.6 cm). After completed
trials, captured images were used to score the height climbed for each fly.
Climbing ability was calculated as the average of five sequential trials. Ten
flies per genotype were assessed in five replicates.
Viability and lifespan of adult flies
Animals were kept at 25°C or 29°C until they were eclosed. Ten flies of the
same sex were then kept in 12 ml vials with standard fly food at room
temperature (22°C). Flies were regularly transferred to new food vials, and
dead flies were recorded every three days until day 30 (0, 3, 6, 9, 12, 15, 18,
21, 24, 27 and 30). Day 0 denotes eclosion. Fly lifespan analysis was
performed in three replicates.
Immunofluorescence and confocal microscopy of larval and
adult flies
The immunofluorescence analysis was performed as described previously
(Dahl-Halvarsson et al., 2018). Dissected body wall muscles from third
instar larvae and IFM from pupae and adult flies (4-day-old and 2- and
5-week-old flies) were fixed with 4% formaldehyde for 10 min. Samples
were permeabilised in PBS containing 2% bovine serum albumin and 1%
Triton X-100 for 30 min, and then incubated overnight at 4°C with primary
antibodies. The following primary antibodies were used: IgG mouse anti-
Myosin (1:100, kindly provided by Dr from J.D. Saide, Boston University,
MA, USA), IgG1 rat anti-Titin/Kettin MAC155 (1:100, Abcam, ab50585),
IgG rabbit anti-Obscurin (1:100, kindly provided by Dr B. Bullard,
University of York, UK) and rabbit anti-Unc45 (1:500 kindly provided by
S.I. Bernstein). The following secondary antibodies, all obtained from
Jackson ImmunoResearch, were used: goat IgG anti-Mouse Cy3 (115-165-
146, 1:1000), donkey IgG anti-rabbit Alexa Fluor 647 (711-605-152, 1:600)
and donkey IgG ant-rat Alexa Fluor 488 (712-545-150, 1:200). Samples
were mounted in Fluoromount-G and imaged using a Confocal LSM800 or
LSM700 microscope (Zeiss) with a 63× objective. Images were processed
using Photoshop (Adobe).
Ultrastructural analysis
Preparation of samples for transmission electron microscopy of IFMs in
adult flies was carried out as described previously (Burkart et al., 2007;
Dahl-Halvarsson et al., 2018). Samples were viewed on a JEOL 1011
electron microscope and images were captured using a Gatan 782 camera.
Protein analysis by Western blot
Relative Mhc expression levels in transgenic lines were determined using
immunoblot analysis. Transgenic lines carryingUAS-eMhc (w−;Mhc1,UAS-
eMhc/+;Mef2-Gal4/+) or UAS-eMhcR1844W (w−;Mhc1,UAS-eMhcR1844W/+;
Mef2-Gal4/+) at 25°C and 29°C, and transgenic flies used in the assessment
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of rescuing the effect of overexpression ofAbba expressing eMhc (w−;Mhc1,
UAS-eMhc/+;UAS-Abba/Mef2-Gal4) or eMhcR1844W (w−;Mhc1,UAS-
eMhcR1844W/+;UAS-Abba/Mef2-Gal4) at 25°C and 29°C, were used. w−
and null Mhc allele (Mhc1) strain flies were used as controls. Protein was
extracted fromMhc1 andUAS-eMhc embryos, and 4-day-old flies from each
line homogenised in radioimmunoprecipitation assay buffer (Thermo Fisher
Scientific, 89901) on ice.Western blot analysis was performed using aMini-
PROTEAN TGX 8-20% gradient gel (Bio-Rad). Protein was blotted onto
LF-PVDF membrane (8 min, 25 V and 2.5A) using a Trans-Blot Turbo
Transfer System (Bio-Rad). Blots were subsequently blocked for 1 h in 5%
milk in TBST buffer (0.1% Tween 20 and 150 mM NaCl in 10 mM
Tris–HCL, pH 7.4) as per the manufacturer’s recommendations. Blots were
probed overnight at 4 degrees with antibodies diluted in PBST (0.1% Tween
20 in PBS). The primary antibodies used were Drosophila myosin
(3E8-3D3), developed by Boston University, and alpha-Tubulin (12G10),
developed by The University of Iowa. Both antibodies were used at 0.2 μg/ml
and obtained from the Developmental Studies Hybridoma Bank, created by
the Eunice Kennedy Shriver National Institute of Child Health and Human
Development (National Institutes ofHealth) andmaintained at TheUniversity
of Iowa. The Secondary antibodies used for detection were: starbright goat
anti-mouse IgG (1:2500, 12004158, Bio-Rad). All wash stages were
3×10 min in TBST 0.1%. Secondary antibodies were incubated for 1 h at
room temperature.
Statistical analysis
Graphs and statistical comparisons were generated using IBM SPSS 20
Statistics. Statistical data are presented as mean±s.e.m. Survival data were
analysed with the Kaplan–Meier estimator, and statistical comparisons were
made with log-rank pairwise analysis. Statistical significance for locomotor
effects was determined by an unpaired two-tailed Student’s t-test. The mean
difference was considered to be statistically significant at the 95%
confidence level. Results were considered as not significant (ns) when
P>0.05, very significant when P=0.01<P<0.05 (*) and extremely
significant when P<0.001 (**). Figures were assembled with Adobe
Photoshop and Illustrator CC 2015.5 (Adobe).
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